Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 49, 2019 - Issue 22
475
Views
15
CrossRef citations to date
0
Altmetric
Original Article

The cytotoxic activities of imidazole derivatives prepared from various guanylhydrazone and phenylglyoxal monohydrate

, ORCID Icon &
Pages 3198-3209 | Received 23 Jul 2019, Published online: 06 Sep 2019

References

  • Verma, A.; Joshi, S.; Singh, D. Imidazole: Having Versatile Biological Activities. J. Chem. 2013, 2013, 1–12. DOI: 10.1155/2013/329412.
  • Chaudhry, F.; Naureen, S.; Ashraf, M.; Al-Rashida, M.; Jahan, B.; Munawar, M. A.; Khan, M. A. Imidazole-Pyrazole Hybrids: Synthesis, Characterization and In-Vitro Bioevaluation against α-Glucosidase Enzyme with Molecular Docking Studies. Bioorg. Chem. 2019, 82, 267–273. DOI: 10.1016/j.bioorg.2018.10.047.
  • Choi, J. H.; Abe, N.; Tanaka, H.; Fushimi, K.; Nishina, Y.; Morita, A.; Kiriiwa, Y.; Motohashi, R.; Hashizume, D.; Koshino, H.; Kawagishi, H. Plant-Growth Regulator, Imidazole-4-Carboxamide, Produced by the Fairy Ring Forming Fungus Lepista sordida. J. Agric. Food Chem. 2010, 58, 9956–9959. DOI: 10.1021/jf101619a.
  • Bhatnagar, A.; Sharma, P. K.; Kumar, N. A Review on “Imidazoles”: Their Chemistry and Pharmacological Potentials. Int. J. Pharmtech. Res. 2011, 3, 268–282.
  • Zhang, S.; Xu, Z.; Gao, C.; Ren, Q. C.; Le, C.; Lv, Z. S.; Feng, L. S. Triazole Derivatives and Their anti-Tubercular Activity. Eur. J. Med. Chem. 2017, 138, 501–513. DOI: 10.1016/j.ejmech.2017.06.051.
  • Hu, Y. Q.; Xu, Z.; Zhang, S.; Wu, X.; Ding, J. W.; Lv, Z. S.; Feng, L. S. Recent Developments of Coumarin-Containing Derivatives and Their anti-Tubercular Activity. Eur. J. Med. Chem. 2017, 136, 122–130. DOI: 10.1016/j.ejmech.2017.05.004.
  • Zhang, H. Z.; Zhao, Z. L.; Zhou, C. H. Recent Advance in Oxazole-Based Medicinal Chemistry. Eur. J. Med. Chem. 2018, 144, 444–492. DOI: 10.1016/j.ejmech.2017.12.044.
  • Akhtar, J.; Khan, A. A.; Ali, Z.; Haider, R.; Yar, M. S. Structure-Activity Relationship (SAR) Study and Design Strategies of Nitrogen-Containing Heterocyclic Moieties for Their Anticancer Activities. Eur. J. Med. Chem. 2017, 125, 143–189. DOI: 10.1016/j.ejmech.2016.09.023.
  • Hu, Y.; Shen, Y. F.; Wu, X. H.; Tu, X.; Wang, G. X. Synthesis and Biological Evaluation of Coumarin Derivatives Containing Imidazole Skeleton as Potential Antibacterial Agents. Eur. J. Med. Chem. 2018, 143, 958–969. DOI: 10.1016/j.ejmech.2017.11.100.
  • Zhang, G. F.; Zhang, S.; Pan, B. F.; Liu, X. F.; Feng, L. S. 4-Quinolone Derivatives and Their Activities against Gram Positive Pathogens. Eur. J. Med. Chem. 2018, 143, 710–723. DOI: 10.1016/j.ejmech.2017.11.082.
  • Xu, Y. X.; Wang, H.; Li, X. K.; Dong, S. N.; Liu, W. W.; Gong, Q.; Wang, T. D. Y.; Tang, Y.; Zhu, J.; Li, J.; et al. Discovery of Novel Propargylamine-Modified 4-Aminoalkyl Imidazole Substituted Pyrimidinylthiourea Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease. Eur. J. Med. Chem. 2018, 143, 33–47. DOI: 10.1016/j.ejmech.2017.08.025.
  • Hu, X. L.; Xu, Z.; Liu, M. L.; Feng, L. S.; Zhang, G. D. Recent Developments of Coumarin Hybrids as Anti-Fungal Agents. Curr. Top. Med. Chem. 2017, 17, 3219–3231. DOI: 10.2174/1568026618666171215100326.
  • Wittine, K.; Babi, M. S.; Makuc, D.; Plavec, J.; Paveli, S. K.; Sedi, M.; Paveli, K.; Leyssen, P.; Neyts, J.; Balzarini, J.; Mintas, M. Novel 1,2,4-Triazole and Imidazole Derivatives of l-Ascorbic and Imino-Ascorbic Acid: Synthesis, Anti-HCV and Antitumor Activity Evaluations. Bioorg. Med. Chem. 2012, 20, 3675–3685. DOI: 10.1016/j.bmc.2012.01.054.
  • Serrao, E.; Xu, Z. L.; Debnath, B.; Christ, F.; Debyser, Z.; Long, Y. Q.; Neamati, N. Discovery of a Novel 5-Carbonyl-1H-Imidazole-4-Carboxamide Class of Inhibitors of the HIV-1 Integrase-LEDGF/p75 Interaction. Bioorg. Med. Chem. 2013, 21, 5963–5972. DOI: 10.1016/j.bmc.2013.07.047.
  • Vlahakis, J. Z.; Kinobe, R. T.; Nakatsu, K.; Szarek, W. A.; Crandall, I. E. Anti-Plasmodium Activity of Imidazole-Dioxolane Compounds. Bioorg. Med. Chem. Lett. 2006, 162, 396–2406. DOI: 10.1016/j.bmcl.2006.01.122.
  • Hu, Y. Q.; Gao, C.; Zhang, S.; Xu, L.; Xu, Z.; Feng, L. S.; Wu, X.; Zhao, F. Quinoline Hybrids and Their Antiplasmodial and Antimalarial Activities. Eur. J. Med. Chem. 2017, 139, 22–47. DOI: 10.1016/j.ejmech.2017.07.061.
  • Bistrovic, A.; Krstulovic, L.; Harej, A.; Grbcic, P.; Sedic, M.; Kostrun, S.; Pavelic, S. K.; Bajic, M.; Raic-Malic, S. Design, Synthesis and Biological Evaluation of Novel Benzimidazole Amidines as Potent Multi-Target Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Eur. J. Med. Chem. 2018, 143, 1616–1634. DOI: 10.1016/j.ejmech.2017.10.061.
  • Xu, Z.; Gao, C.; Ren, Q. C.; Song, X. F.; Feng, L. S.; Lv, Z. S. Recent Advances of Pyrazole-Containing Derivatives as Anti-Tubercular Agents. Eur. J. Med. Chem. 2017, 139, 429–440. DOI: 10.1016/j.ejmech.2017.07.059.
  • Debus, H. Über Die Einwirkung Des Ammoniaks Auf Glyoxal. Ann. Chem. Pharm. 2006, 107, 199–208. DOI: 10.1002/jlac.18581070209.
  • Thornalley, P. J.; George, A. Y.; Argirov, O. K. Kinetics and Mechanism of the Reaction of Aminoguanidine with the α-Oxoaldehydes Glyoxal, Methylglyoxal, and 3-Deoxyglucosone under Physiological Conditions. Biochem Pharmacol. 2000, 60, 55–65. DOI: 10.1016/S0006-2952(00)00287-2.
  • Bengelsdorf, I. S. A Reaction of Guanidine with Glyoxals in Aqueous Solution. The Preparation of Glycocyamidines. J. Am. Chem. Soc. 1953, 75, 3138–3140. DOI: 10.1021/ja01109a028.
  • Panicucci, R.; Mcclelland, R. 4,5-Dihydro-4,5-Dihydroxyimidazoles as Products of the Reduction of 2-Nitroimidazoles. HPLC Assay and Demonstration of Equilibrium Transfer of Glyoxal to Guanine. Can. J. Chem. 1989, 67, 2128–2135. DOI: 10.1139/v89-331.
  • Rani, N.; Sharma, A.; Singh, R. Mini-Reviews in Organic Chemistry, Trisubstituted Imidazole Synthesis: A Review. Mini Rev Org Chem. 2014, 12, 34–65. DOI: 10.2174/1570193X11666141028235010.
  • Kumar, D.; Thomas, K. R. J.; Lee, C. P.; Ho, K. C. Organic Dyes Containing Fluorene Decorated with Imidazole Units for Dye-Sensitized Solar Cells. J. Org. Chem. 2014, 79, 3159–3172. DOI: 10.1021/jo500330r.
  • Sharma, D.; Narasimhan, B.; Kumar, P.; Judge, V.; Narang, R.; De Clercq, E.; Balzarini, J. Synthesis, Antimicrobial and Antiviral Evaluation of Substituted Imidazole Derivatives. Eur. J. Med. Chem. 2009, 44, 2347–2353. DOI: 10.1016/j.ejmech.2008.08.010.
  • Stover, C. K.; Warrener, P.; VanDevanter, D. R.; Sherman, D. R.; Arain, T. M.; Langhorne, M. H.; Anderson, S. W.; Towell, J. A.; Yuan, Y.; McMurray, D. N.; et al. A Small-Molecule Nitroimidazopyran Drug Candidate for the Treatment of Tuberculosis. Nature 2000, 405, 962–966. DOI: 10.1038/35016103.
  • Cai, J.; Li, S.; Zhou, C.; Wu, J. Advance in Research of Imidazoles as Anti-Tumor Agents. Chin J New Drugs 2009, 18, 598–608.
  • Cherkofsky, S. C.; Sharpe, T. R.; Inventors EI Du Pont de Nemours, Assignee. Anti-inflammatory 4,5-Diarly-2-(substituted-thio) Imidazoles and Their Corresponding Sulfoxides and Sulfones. U.S. Patent 4,190,666, 1980.
  • Khabnadideh, S. Z.; Motazedian, R. M.; Eskandari, M. Synthesis of Metronidazole Derivatives as Antigiardiasis Agents. Daru J. Pharm. Sci. 2007, 15, 17–20.
  • Sánchez-Moreno, M.; Gómez-Contreras, F.; Navarro, P.; Marín, C.; Ramírez-Macías, I.; Olmo, F.; Sanz, A. M.; Campayo, L.; Cano, C.; Yunta, M. J. In Vitro Leishmanicidal Activity of Imidazole-or Pyrazole-Based Benz[g]Phthalazine Derivatives against Leishmania infantum and Leishmania braziliensis Species. J. Antimicrob. Chemother. 2012, 67, 387–397. DOI: 10.1093/jac/dkr480.
  • Piérard, G.; Vroome, V.; Borgers, M.; Cauwenbergh, G. Pierard-Franchimont, C. New Insights in the Effects of Topical Ketoconazole. Curr. Top. Pharmacol. 2006, 10, 59–65.
  • Hancock, A. A.; Bennani, Y. L.; Bush, E. N.; Esbenshade, T. A.; Faghih, R.; Fox, G. B.; Jacobson, P.; Knourek-Segel, V.; Krueger, K. M.; Nuss, M. E.; et al. Antiobesity Effects of A-331440, a Novel Non-Imidazole Histamine H3 Receptor Antagonist. Eur. J. Pharmacol. 2004, 487, 183–197. DOI: 10.1016/j.ejphar.2004.01.015.
  • Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Price, W. A.; Santella, J. B., III; Wells, G. J.; Wexler, R. R. Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of N-(Biphenylylmethyl) Imidazoles as Potent, Orally Active Antihypertensives. J. Med. Chem. 1991, 34, 2525–2547. DOI: 10.1021/jm00112a031.
  • Narasimhan, B.; Sharma, D.; Kumar, P. Biological Importance of Imidazole Nucleus in the New Millennium. Med. Chem. Res. 2011, 20, 1119–1140. DOI: 10.1007/s00044-010-9472-5.
  • Dimova, D.; Iyer, P.; Vogt, M.; Totzke, F.; Kubbutat, M. H. G.; Schächtele, C.; Laufer, S.; Bajorath, J. Assessing the Target Differentiation Potential of Imidazole-Based Protein Kinase Inhibitors. J. Med. Chem. 2012, 55, 11067–11071. DOI: 10.1021/jm3014508.
  • Zhang, L.; Peng, X. M.; Damu, G. L.; Geng, R. X.; Zhou, C. H. Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry. Med. Res. Rev. 2014, 34, 340–437. DOI: 10.1002/med.21290.
  • Kumar, S.; Ceruso, M.; Tuccinardi, T.; Supuran, C. T.; Sharma, P. K. Pyrazolylbenzo[d]Imidazoles as New Potent and Selective Inhibitors of Carbonic Anhydrase Isoforms hCA IX and XII. Bioorg. Med. Chem. 2016, 24, 2907–2913. DOI: 10.1016/j.bmc.2016.04.061.
  • Ali, I.; Lone, M.; Al-Othman, Z.; Al-Warthan, A.; Sanagi, M. Heterocyclic Scaffolds: Centrality in Anticancer Drug Development. Curr. Drug Targets 2015, 16, 711–734. DOI: 10.2174/1389450116666150309115922.
  • Chourasiya, S. S.; Kathuria, D.; Nikam, S. S.; Ramakrishnan, A.; Khullar, S.; Mandal, S. K.; Chakraborti, A. K.; Bharatam, P. V. Azine-Hydrazone Tautomerism of Guanylhydrazones: Evidence for the Preference toward the Azine Tautomer. J. Org. Chem. 2016, 81, 7574–7583. DOI: 10.1021/acs.joc.6b01258.
  • Gomha, S. M.; Hassaneen, H. M. E. Synthesis and Antimicrobial Activity of Some New Pyrazoles, Fused Pyrazolo[3,4-d]-Pyrimidine and 1,2-Dihydroimidazo-[2,1-c][1,2,4]Triazin-6-One Derivatives. Molecules 2011, 16, 6549–6560. DOI: 10.3390/molecules16086549.
  • Samai, S.; Nandi, G. C.; Singh, P.; Singh, M. S. An Efficient Catalyst for the One-Pot Synthesis of 2,4,5-Tri Substituted and 1,2,4,5-Tetra Substituted Imidazoles. Tetrahedron 2009, 65, 10155–10161. DOI: 10.1016/j.tet.2009.10.019.
  • Akkoç, S. Derivatives of 1-(2-(Piperidin-1-yl)Ethyl)-1H-Benzo[d]Imidazole: Synthesis, Characterization, Determining of Electronic Properties and Cytotoxicity Studies. ChemistrySelect 2019, 4, 4938–4943. DOI: 10.1002/slct.201900353.
  • Akkoç, S.; Kayser, V.; İlhan, Ö. İ. Synthesis and in Vitro Anticancer Evaluation of Some Benzimidazolium Salts. J. Heterocycl. Chem. 2019. DOI: 10.1002/jhet.3687. In press.
  • Yıldız, U.; Şengül, A.; Kandemir, I.; Cömert, F.; Akkoç, S.; Coban, B. The Comparative Study of the DNA Binding and Biological Activities of the Quaternized Dicnq as a Dicationic Form and Its Platinum(II) Heteroleptic Cationic Complex. Bioorg Chem. 2019, 87, 70. DOI: 10.1016/j.bioorg.2019.03.009.
  • Akkoç, S. Antiproliferative Activities of 2-Hydroxyethyl Substituted Benzimidazolium Salts and Their Palladium Complexes against Human Cancerous Cell Lines. Synth. Commun. 2019. DOI: 10.1080/00397911.2019.1650187. In press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.